ANKRD30BP3: A Potential Drug Target and Biomarker (G338579)

Target Name: ANKRD30BP3

NCBI ID: G338579

ANKRD30BP3

Other Name(s): Ankyrin repeat domain 30B pseudogene 3 | ankyrin repeat domain 30B pseudogene 3

ANKRD30BP3: A Potential Drug Target and Biomarker

Ankyrin repeat domains are a type of gene duplication that occurs in many organisms, including humans. These domains have been implicated in various biological processes and have been identified as potential drug targets or biomarkers. One such gene, ANKRD30BP3, has recently been identified and is being investigated for its potential drug target and biomarker properties.

The ANKRD30BP3 gene is located on chromosome 16 and encodes a protein with a unique structure that includes an ankyrin repeat domain. The ankyrin repeat is a specific type of gene duplication that is characterized by the repeated sequence of the amino acids Asp or Asn at a specific location in the protein sequence. The ankyrin repeat has been identified as a potential drug target in various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

Expression of ANKRD30BP3 has been demonstrated in various tissues and biological samples, including human tissues, neurons, and cancer cells. Studies have shown that ANKRD30BP3 is expressed in a variety of tissues and can be used as a potential biomarker for disease diagnosis and monitoring.

In addition to its potential as a drug target, ANKRD30BP3 has also been shown to have potential as a biomarker for various diseases. For example, studies have shown that ANKRD30BP3 is expressed in the brains of individuals with Alzheimer's disease and that it is associated with the progression of the disease. Similarly, ANKRD30BP3 has been shown to be expressed in the blood vessels of individuals with cardiovascular disease and that it may be a potential biomarker for this disease.

The potential drug targeting of ANKRD30BP3 is based on its unique structure and the fact that it is expressed in various tissues. ANKRD30BP3 has been shown to interact with various proteins, including the protein targets known as PD-L1 and PD-L2. These interactions suggest that ANKRD30BP3 may be a good candidate for drug targeting.

In conclusion, ANKRD30BP3 is a gene that has been identified as a potential drug target and biomarker. Its unique structure and the fact that it is expressed in various tissues make it an attractive candidate for drug targeting. Further research is needed to determine the full potential of ANKRD30BP3 as a drug target and biomarker.

Protein Name: Ankyrin Repeat Domain 30B Pseudogene 3

The "ANKRD30BP3 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ANKRD30BP3 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets